Ronghui Zhou

Johnson & Johnson (United States)

Papers

1

Total Citations

6

H-Index

1

About

Ronghui Zhou is a leading figure in analytical chemistry and drug discovery, specializing in the development of high-throughput separation and mass spectrometry platforms. Their most notable contribution is the creation of automated systems that integrate reversed-phase high-performance liquid chromatography (RP-HPLC) and supercritical fluid chromatography (SFC) with mass spectrometry, dramatically accelerating the analysis and purification of compounds in pharmaceutical research. This work, detailed in their 2024 paper "Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery," has already garnered 6 citations, reflecting its immediate relevance to streamlining drug development pipelines. Zhou's innovations enable rapid, reproducible screening of large chemical libraries, reducing bottlenecks in lead optimization and quality control. By merging cutting-edge automation with robust analytical techniques, they have enhanced the efficiency and scalability of drug discovery workflows, impacting both academic and industrial settings. Their research continues to push the boundaries of analytical methodology, offering practical solutions for complex separation challenges and positioning them as a key contributor to modern pharmaceutical science.

Research Focus

Key Achievements

1
H-Index
1
Papers
6
Total Citations
6
Avg Citations/Paper
🏆 Most Cited Paper
Automated high-throughput RP-HPLC-MS and SFC-MS analytical and purification platforms to support drug discovery
6 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago